Christophe Renou

Author PubWeight™ 33.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Zoonotic hepatitis E: animal reservoirs and emerging risks. Vet Res 2010 2.26
2 Quantitative study of digestive enzyme secretion and gastrointestinal lipolysis in chronic pancreatitis. Clin Gastroenterol Hepatol 2005 2.14
3 Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin. Gastroenterology 2006 2.07
4 A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis. J Hepatol 2010 2.02
5 Interstitial pneumonia recurrence during chronic hepatitis C treatment. Am J Gastroenterol 2005 1.60
6 Treatment of chronic hepatitis C with pegylated interferon and ribavirin in treatment-naive patients in 'true life': a plea in favor of independent postmarketing evaluations. Eur J Gastroenterol Hepatol 2010 1.51
7 Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study. Am J Gastroenterol 2006 1.49
8 A national French survey on the use of growth factors as adjuvant treatment of chronic hepatitis C. Hepatology 2007 1.39
9 Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comp Hepatol 2005 1.25
10 Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C. J Hepatol 2006 1.14
11 A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus. Eur J Gastroenterol Hepatol 2011 1.12
12 A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis. Hepatology 2011 1.12
13 Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study. J Hepatol 2006 0.94
14 Pitfalls of cyst fluid findings obtained by endoscopic ultrasonography fine-needle aspiration on a pancreatic lymphoepithelial cyst. Am J Gastroenterol 2007 0.93
15 Lymph node enlargement within the hepatoduodenal ligament in patients with chronic hepatitis C reflects the immunological cellular response of the host. J Hepatol 2003 0.92
16 A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France. J Hepatol 2012 0.92
17 Foodborne transmission of hepatitis E virus from raw pork liver sausage, France. Emerg Infect Dis 2014 0.89
18 Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease. J Infect Dis 2002 0.86
19 Hepatitis E: a curious zoonosis. Front Biosci 2008 0.84
20 Does the pancreas really produce much more lipase than required for fat digestion? JOP 2005 0.84
21 Physiological study of pH stability and sensitivity to pepsin of human gastric lipase. Digestion 2002 0.82
22 Treatment of hepatitis delta chronic infection: HBs antigen quantification may help monitoring, and HBs antigen seroconversion could be the ideal 'end' point of treatment. J Clin Virol 2012 0.79
23 Prospective study of Hepatitis E Virus infection among pregnant women in France. Virol J 2014 0.78
24 Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: complete biochemical and histological response to therapy with ursodesoxycholic acid. J Gastroenterol Hepatol 2006 0.78
25 Pathogenesis of Hepatitis E in pregnancy. Liver Int 2008 0.78
26 Resolution of chronic hepatitis delta infection after five years of peginterferon-adefovir: lessons from a case report. Clin Res Hepatol Gastroenterol 2013 0.77
27 Hepatitis B reactivation in patients with inflammatory bowel disease: A prospective survey on screening and prevention practices at general hospitals in France. Inflamm Bowel Dis 2011 0.77
28 Threshold for neutropenia in the adjustment of interferon treatment in HCV infection. Hepatology 2003 0.76
29 External validation of FibroIndex. Hepatology 2007 0.76
30 High dose daily interferon-alpha induction and secondary adjunction of ribavirin in treatment-naive patients with chronic hepatitis C. A multicentric, randomised, controlled trial. Gastroenterol Clin Biol 2006 0.76
31 Controversies about the histological features of chronic HCV patients with persistently normal alanine transaminase levels: what can be done about the present definition? Gastroenterology 2002 0.75
32 Hepatogastroenterologists' knowledge of inactive carriers and immunotolerant hepatitis B virus patients in France: results of a practice survey. Eur J Gastroenterol Hepatol 2015 0.75
33 Chronic hepatitis E virus infection in a cirrhotic patient: A case report. Medicine (Baltimore) 2017 0.75